(Q38021811)

27 August 2017

title

Developments in the prevention of transfusion-associated graft-versus-host disease (English)

1 reference

27 August 2017

Loren D Fast

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

26 June 2012

1 reference

British Journal of Haematology

27 August 2017

published in

1 reference

27 August 2017

volume

158

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

563-568

1 reference

A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Inhibition of murine GVHD by PEN110 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Minor histocompatibility antigens: from transplantation problems to therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Reversing T cell immunosenescence: why, who, and how

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

White blood cell inactivation after treatment with riboflavin and ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

HLA-matched sibling bone marrow transplantation for β-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Pathogen reduction of blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Serious hazards of transfusion: a decade of hemovigilance in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09197.X

10.1111/J.1365-2141.2012.09197.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference